PMHNP Exam Practice Test 1&2, BOTH
COMBINED. 350QUESTIONS AND
answers
Q1. A 45-year-old patient is concerned about his mental health and has a family
history of
schizophrenia. The psychiatric-mental health nurse practitioner's initial action is
to:
A. Reassure the patient that genetic factors alone do not determine mental health.
B. Recommend immediate genetic testing for a precise diagnosis.
C. Assess the patient's current stressors and coping mechanisms.
D. Suggest starting antipsychotic medication as a preventive measure.
Q2. A 35-year-old patient is considering medication-assisted treatment having a
history of
substance use disorder. The psychiatric-mental health nurse practitioner's
primary consideration
should be:
A. Administering a benzodiazepine for immediate relief.
B. Assessing the patient's readiness for behavioral therapy.
C. Prescribing an opioid antagonist to deter substance use.
D. Evaluating liver function before initiating any pharmacotherapy.
Q3. A patient is at risk for a serious drug interaction as both a monoamine
oxidase inhibitor (MAOI)
and a selective serotonin reuptake inhibitor (SSRI) are prescribed. The
psychiatric-mental health
nurse practitioner recognizes this risk primarily involves:
A. Pharmacokinetic interactions affecting drug metabolism.
B. Pharmacodynamic interactions altering receptor sensitivity.
C. Therapeutic duplication leading to cumulative effects.
D. Dietary supplement-drug interactions impacting SSRI efficacy.
Q4. A patient diagnosed with a bacterial infection is on a stable dose of an
antipsychotic medication
and prescribed an antibiotic. The psychiatric-mental health nurse practitioner
anticipates potential
interactions related to the following:
A. Pharmacokinetic interactions affecting drug metabolism.
B. Pharmacodynamic interactions altering receptor sensitivity.
C. Therapeutic duplication leading to cumulative effects.
D. Dietary supplement-drug interactions influencing medication efficacy.
Q5. A 55-year-old patient is asking about the potential benefits of
complementary and alternative
medicine (CAM), diagnosed with PTSD. The psychiatric-mental health nurse
practitioner should:
A. Dismiss CAM as ineffective and potentially harmful.
B. Discuss various CAM modalities and their potential benefits.
C. Recommend surgery as a more effective treatment option.
D. Suggest increasing medication dosage instead.
,Q6. A 22-year-old patient with schizophrenia is prescribed clozapine, a drug
known for potential
variations in drug response due to genetic factors. What precautions should the
psychiatric-mental
health nurse practitioner consider when managing this patient's medication?A.
Monitor for changes in environmental and developmental factors.
B. Conduct genetic testing to identify potential drug-metabolizing enzyme variations.
C. Adjust the medication dosage based on patient feedback.
D. Explore alternative antipsychotic medications to minimize genetic variability.
Q7. An 8-year-old child is prescribed medication for
attention-deficit/hyperactivity disorder
(ADHD). The psychiatric-mental health nurse practitioner recognizes the need
for specialized
monitoring due to the child's age. What consideration should be prioritized in
the management of
potential adverse drug reactions for this pediatric patient?
A. Increased risk of fatal reactions in children under 5 years old
B. Regular monitoring for therapeutic drug levels
C. Potential adverse effects associated with ADHD medications
D. Genetic factors influencing drug metabolism in children
Q8. A 45-year-old patient, recently started on a new antipsychotic medication,
reports involuntary
movements and muscle stiffness. The psychiatric-mental health nurse
practitioner recognizes these
symptoms as indicative of:
A. A predictable dose-related adverse drug reaction.
B. An idiosyncratic adverse drug reaction.
C. An allergic adverse drug reaction.
D. A therapeutic response to the medication.
Q9. A patient develops an itchy rash, upper airway edema, and hypotension after
taking a new
medication. The psychiatric-mental health nurse practitioner identifies these
symptoms as indicative
of:
A. Predictable dose-related adverse drug reaction.
B. Idiosyncratic adverse drug reaction.
C. Allergic adverse drug reaction.
D. Therapeutic response to the medication.
Q10. A patient on long-term medication experiences dose-related adverse
reactions. The
psychiatric-mental health nurse practitioner contemplates modifying the dose or
eliminating
precipitating factors. This approach is most applicable when adverse reactions
involve:
A. Idiosyncratic responses.
B. Allergic reactions.
C. Opioid-induced constipation.
D. Hypotension and upper airway edema.
Q11. A patient on psychiatric medications presents with nasal congestion. What
intervention should
,the psychiatric-mental health nurse practitioner recommend to manage this side
effect?
A. Nasal drops and moisturizer; avoid nasal spray.
B. Prescribe a systemic antihistamine; consider a medication change.
C. Dark glasses and sunblock; cover all exposed areas.D. Monitor for infections;
withhold medication for sinus tachycardia.
Q12. A 30-year-old patient is prescribed a new psychiatric medication with a
history of anaphylactic
reactions. What term describes the situation where retaking the medication
could harm the patient?
A. Absolute contraindication.
B. Relative contraindication.
C. Pharmacokinetics.
D. Bioavailability.
Q13. A 60-year-old patient is prescribed medication for a psychiatric condition,
and the nurse
practitioner is concerned about potential complications due to the patient's fluid
status and body
habitus. What aspect of drug distribution is the nurse considering?
A. Diffusion and convection.
B. Liberation in the stomach.
C. Effective drug concentration.
D. Volume of distribution.
Q14. A psychiatric-mental health nurse practitioner prescribes a lipophilic
medication with a large
volume of distribution (Vd) to a patient with significant adipose tissue. How does
the patient's
adipose tissue influence the Vd of the drug?
A. Reduces Vd due to decreased distribution into extracellular fluid.
B. Increases Vd as the drug distributes throughout adipose tissues.
C. Maintains a constant Vd despite adipose tissue composition.
D. Renders lipophilic medications ineffective.
Q15. A psychiatric-mental health nurse practitioner treats a patient with
decreased serum protein
levels due to malnutrition. How might this nutritional status impact the
pharmacological effects of
protein-bound medications?
A. Decreases the risk of adverse effects.
B. Has no impact on protein-bound medications.
C. Increases the risk of adverse effects.
D. Accelerates drug metabolism.
Q16. In an interprofessional team caring for a patient, what role does the
psychiatric-mental health
nurse practitioner play in ensuring the safety and efficacy of pharmacotherapy?
A. Primary responsibility for administering medications.
B. Verifying dosing, drug interactions, and monitoring plasma concentrations.
C. Solely educating the patient on self-administration of medications.
D. Minimizing communication with other team members to avoid conflicts.
Q17. As part of the interprofessional team caring for a patient, the psychiatric-
mental health nurse
, practitioner plays a crucial role in ensuring the safety and efficacy of
pharmacotherapy by:
A. Primary responsibility for administering medications.B. Verifying dosing, drug
interactions, and monitoring plasma concentrations.
C. Solely educating the patient on self-administration of medications.
D. Minimizing communication with other team members to avoid conflicts.
Q18. A 22-year-old patient is prescribed methylphenidate and diagnosed with
attention deficit
hyperactivity disorder (ADHD). The psychiatric-mental health nurse
practitioner considers the
drug's pharmacokinetics. Why is it important to monitor the patient's response
over time?
A. To determine the patient's financial capacity for long-term medication use.
B. To estimate the time it takes for the drug to leave the patient's system.
C. To assess the patient's ability to self-administer and store the medication.
D. To evaluate the medication's popularity among other patients.
Q19. In pharmacodynamics, drugs can interact with various protein targets.
What drug interaction
occurs when a drug binds a receptor but does not activate it, preventing its
normal action?
A. Inhibitor action, blocking receptor activation.
B. Stabilizing action, maintaining general receptor activation.
C. Agonist action, mimicking receptor activation.
D. Exchanging action, replacing substances for reserve formation.
Q20. A 45-year-old patient prescribed first-generation antipsychotic presents
with abnormal
posturing, repetitive movements, and muscle contractions. The psychiatric-
mental health nurse
practitioner recognizes these symptoms as:
A. Akathisia
B. Tardive dyskinesia
C. Dystonia
D. Drug-induced parkinsonism
Q21. A psychiatric-mental health nurse practitioner teaches a colleague about
receptor binding and
effect. How does the law of mass action govern the binding of ligands (drugs) to
receptors?
A. It determines receptor occupancy, and the equilibrium dissociation constant is the
total duration of a
substance.
B. It governs the relationship between occupancy and pharmacological response, with
the equilibrium
dissociation constant indicating ligand-receptor binding.
C. It relates to offset phase in drug use, and the equilibrium dissociation constant
represents peak
concentration.
D. It measures the fraction of receptor bound by the ligand, and the equilibrium
dissociation constant is
the onset phase.
COMBINED. 350QUESTIONS AND
answers
Q1. A 45-year-old patient is concerned about his mental health and has a family
history of
schizophrenia. The psychiatric-mental health nurse practitioner's initial action is
to:
A. Reassure the patient that genetic factors alone do not determine mental health.
B. Recommend immediate genetic testing for a precise diagnosis.
C. Assess the patient's current stressors and coping mechanisms.
D. Suggest starting antipsychotic medication as a preventive measure.
Q2. A 35-year-old patient is considering medication-assisted treatment having a
history of
substance use disorder. The psychiatric-mental health nurse practitioner's
primary consideration
should be:
A. Administering a benzodiazepine for immediate relief.
B. Assessing the patient's readiness for behavioral therapy.
C. Prescribing an opioid antagonist to deter substance use.
D. Evaluating liver function before initiating any pharmacotherapy.
Q3. A patient is at risk for a serious drug interaction as both a monoamine
oxidase inhibitor (MAOI)
and a selective serotonin reuptake inhibitor (SSRI) are prescribed. The
psychiatric-mental health
nurse practitioner recognizes this risk primarily involves:
A. Pharmacokinetic interactions affecting drug metabolism.
B. Pharmacodynamic interactions altering receptor sensitivity.
C. Therapeutic duplication leading to cumulative effects.
D. Dietary supplement-drug interactions impacting SSRI efficacy.
Q4. A patient diagnosed with a bacterial infection is on a stable dose of an
antipsychotic medication
and prescribed an antibiotic. The psychiatric-mental health nurse practitioner
anticipates potential
interactions related to the following:
A. Pharmacokinetic interactions affecting drug metabolism.
B. Pharmacodynamic interactions altering receptor sensitivity.
C. Therapeutic duplication leading to cumulative effects.
D. Dietary supplement-drug interactions influencing medication efficacy.
Q5. A 55-year-old patient is asking about the potential benefits of
complementary and alternative
medicine (CAM), diagnosed with PTSD. The psychiatric-mental health nurse
practitioner should:
A. Dismiss CAM as ineffective and potentially harmful.
B. Discuss various CAM modalities and their potential benefits.
C. Recommend surgery as a more effective treatment option.
D. Suggest increasing medication dosage instead.
,Q6. A 22-year-old patient with schizophrenia is prescribed clozapine, a drug
known for potential
variations in drug response due to genetic factors. What precautions should the
psychiatric-mental
health nurse practitioner consider when managing this patient's medication?A.
Monitor for changes in environmental and developmental factors.
B. Conduct genetic testing to identify potential drug-metabolizing enzyme variations.
C. Adjust the medication dosage based on patient feedback.
D. Explore alternative antipsychotic medications to minimize genetic variability.
Q7. An 8-year-old child is prescribed medication for
attention-deficit/hyperactivity disorder
(ADHD). The psychiatric-mental health nurse practitioner recognizes the need
for specialized
monitoring due to the child's age. What consideration should be prioritized in
the management of
potential adverse drug reactions for this pediatric patient?
A. Increased risk of fatal reactions in children under 5 years old
B. Regular monitoring for therapeutic drug levels
C. Potential adverse effects associated with ADHD medications
D. Genetic factors influencing drug metabolism in children
Q8. A 45-year-old patient, recently started on a new antipsychotic medication,
reports involuntary
movements and muscle stiffness. The psychiatric-mental health nurse
practitioner recognizes these
symptoms as indicative of:
A. A predictable dose-related adverse drug reaction.
B. An idiosyncratic adverse drug reaction.
C. An allergic adverse drug reaction.
D. A therapeutic response to the medication.
Q9. A patient develops an itchy rash, upper airway edema, and hypotension after
taking a new
medication. The psychiatric-mental health nurse practitioner identifies these
symptoms as indicative
of:
A. Predictable dose-related adverse drug reaction.
B. Idiosyncratic adverse drug reaction.
C. Allergic adverse drug reaction.
D. Therapeutic response to the medication.
Q10. A patient on long-term medication experiences dose-related adverse
reactions. The
psychiatric-mental health nurse practitioner contemplates modifying the dose or
eliminating
precipitating factors. This approach is most applicable when adverse reactions
involve:
A. Idiosyncratic responses.
B. Allergic reactions.
C. Opioid-induced constipation.
D. Hypotension and upper airway edema.
Q11. A patient on psychiatric medications presents with nasal congestion. What
intervention should
,the psychiatric-mental health nurse practitioner recommend to manage this side
effect?
A. Nasal drops and moisturizer; avoid nasal spray.
B. Prescribe a systemic antihistamine; consider a medication change.
C. Dark glasses and sunblock; cover all exposed areas.D. Monitor for infections;
withhold medication for sinus tachycardia.
Q12. A 30-year-old patient is prescribed a new psychiatric medication with a
history of anaphylactic
reactions. What term describes the situation where retaking the medication
could harm the patient?
A. Absolute contraindication.
B. Relative contraindication.
C. Pharmacokinetics.
D. Bioavailability.
Q13. A 60-year-old patient is prescribed medication for a psychiatric condition,
and the nurse
practitioner is concerned about potential complications due to the patient's fluid
status and body
habitus. What aspect of drug distribution is the nurse considering?
A. Diffusion and convection.
B. Liberation in the stomach.
C. Effective drug concentration.
D. Volume of distribution.
Q14. A psychiatric-mental health nurse practitioner prescribes a lipophilic
medication with a large
volume of distribution (Vd) to a patient with significant adipose tissue. How does
the patient's
adipose tissue influence the Vd of the drug?
A. Reduces Vd due to decreased distribution into extracellular fluid.
B. Increases Vd as the drug distributes throughout adipose tissues.
C. Maintains a constant Vd despite adipose tissue composition.
D. Renders lipophilic medications ineffective.
Q15. A psychiatric-mental health nurse practitioner treats a patient with
decreased serum protein
levels due to malnutrition. How might this nutritional status impact the
pharmacological effects of
protein-bound medications?
A. Decreases the risk of adverse effects.
B. Has no impact on protein-bound medications.
C. Increases the risk of adverse effects.
D. Accelerates drug metabolism.
Q16. In an interprofessional team caring for a patient, what role does the
psychiatric-mental health
nurse practitioner play in ensuring the safety and efficacy of pharmacotherapy?
A. Primary responsibility for administering medications.
B. Verifying dosing, drug interactions, and monitoring plasma concentrations.
C. Solely educating the patient on self-administration of medications.
D. Minimizing communication with other team members to avoid conflicts.
Q17. As part of the interprofessional team caring for a patient, the psychiatric-
mental health nurse
, practitioner plays a crucial role in ensuring the safety and efficacy of
pharmacotherapy by:
A. Primary responsibility for administering medications.B. Verifying dosing, drug
interactions, and monitoring plasma concentrations.
C. Solely educating the patient on self-administration of medications.
D. Minimizing communication with other team members to avoid conflicts.
Q18. A 22-year-old patient is prescribed methylphenidate and diagnosed with
attention deficit
hyperactivity disorder (ADHD). The psychiatric-mental health nurse
practitioner considers the
drug's pharmacokinetics. Why is it important to monitor the patient's response
over time?
A. To determine the patient's financial capacity for long-term medication use.
B. To estimate the time it takes for the drug to leave the patient's system.
C. To assess the patient's ability to self-administer and store the medication.
D. To evaluate the medication's popularity among other patients.
Q19. In pharmacodynamics, drugs can interact with various protein targets.
What drug interaction
occurs when a drug binds a receptor but does not activate it, preventing its
normal action?
A. Inhibitor action, blocking receptor activation.
B. Stabilizing action, maintaining general receptor activation.
C. Agonist action, mimicking receptor activation.
D. Exchanging action, replacing substances for reserve formation.
Q20. A 45-year-old patient prescribed first-generation antipsychotic presents
with abnormal
posturing, repetitive movements, and muscle contractions. The psychiatric-
mental health nurse
practitioner recognizes these symptoms as:
A. Akathisia
B. Tardive dyskinesia
C. Dystonia
D. Drug-induced parkinsonism
Q21. A psychiatric-mental health nurse practitioner teaches a colleague about
receptor binding and
effect. How does the law of mass action govern the binding of ligands (drugs) to
receptors?
A. It determines receptor occupancy, and the equilibrium dissociation constant is the
total duration of a
substance.
B. It governs the relationship between occupancy and pharmacological response, with
the equilibrium
dissociation constant indicating ligand-receptor binding.
C. It relates to offset phase in drug use, and the equilibrium dissociation constant
represents peak
concentration.
D. It measures the fraction of receptor bound by the ligand, and the equilibrium
dissociation constant is
the onset phase.
